BUFORD, Ga.--(BUSINESS WIRE)--Theragenics Corporation® (NYSE: TGX), a medical device company serving the cancer treatment and surgical products markets, today announced consolidated financial results for first quarter ended April 1, 2007. Consolidated revenue for the quarter was $15.5 million, an increase of $3.1 million, or 25% over the first quarter of 2006. Net earnings for the quarter were $1.2 million or $0.04 per share, compared to net earnings of $775,000 or $0.02 per share in the first quarter of 2006.
